CPV – Page 60 – Pharma.Tips

End-point detection failure during scale-up – GMP-compliant optimization approach

“`html Addressing Failures in End-Point Detection During Scale-Up for Enhanced GMP Compliance In the pharmaceutical manufacturing sector, successful scale-up from laboratory to production levels is critical to meet demand while…

FBD drying inefficiency during wet granulation – inspection-ready justification

Addressing Inefficiencies in FBD Drying During Wet Granulation Processes Filtration and Blending Drying (FBD) inefficiencies during wet granulation can significantly compromise product quality, process yield, and operational efficiency. This article…

Over-wetting risk during validation – inspection-ready justification

Managing Over-Wetting Risks During Validation for Optimal Pharmaceutical Manufacturing In the pharmaceutical industry, the granular adjustment of moisture levels during the validation of granulation processes is critical for achieving optimal…

Granule friability issue during scale-up – inspection-ready justification

Addressing Granule Friability During Scale-Up: Inspection-Ready Solutions Granule friability during scale-up can pose significant risks to product quality and process efficiency in the pharmaceutical manufacturing sector. As organizations aim for…

Over-wetting risk during wet granulation – GMP-compliant optimization approach

Mitigating Over-wetting Risk in Wet Granulation: A Comprehensive GMP Framework The wet granulation process is a critical step in pharmaceutical manufacturing that enhances the flow and compaction characteristics of powder…

FBD drying inefficiency during scale-up – process robustness improvement plan

Enhancing Process Robustness to Address FBD Drying Inefficiency During Scale-Up In the realm of pharmaceutical manufacturing, fluidized bed drying (FBD) is a critical process that can dictate the quality and…

FBD drying inefficiency during wet granulation – process robustness improvement plan

Improving Process Robustness to Address FBD Drying Inefficiency During Wet Granulation In pharmaceutical manufacturing, particularly during the wet granulation process, inefficiencies in fluid bed drying (FBD) can significantly impact batch…

Non-uniform granule size during wet granulation – process robustness improvement plan

Addressing Non-Uniform Granule Size in Wet Granulation: A Robust Improvement Plan The production of pharmaceutical granules with a uniform size is critical to ensuring consistent product quality and performance. Non-uniform…

FBD drying inefficiency during validation – GMP-compliant optimization approach

Addressing Inefficiencies in FBD Drying During Validation: A GMP-Compliant Approach Fluid Bed Dryers (FBD) are critical in pharmaceutical manufacturing, especially during granulation processes. However, inefficiencies in drying can lead to…

RMG torque instability during wet granulation – inspection-ready justification

“`html Addressing Torque Instability in RMG During Wet Granulation: An Inspection-Ready Approach Torque instability in a Rapid Mixer Granulator (RMG) during wet granulation can significantly impact process efficiency, product quality,…

Granule friability issue during validation – GMP-compliant optimization approach

Addressing Granule Friability Challenges During Validation for GMP Compliance Granule friability issues can significantly hinder the pharmaceutical manufacturing process, particularly during the validation phase of granulation. Insufficient granule strength not…

Over-wetting risk during validation – GMP-compliant optimization approach

“`html Effective Strategies to Address Over-wetting Risks During Validation in Pharma Manufacturing In pharmaceutical manufacturing, over-wetting during validation can lead to significant challenges, including reduced product quality, inconsistent batch results,…